- Research works
- 3 fractional, all time
- Citations
- 94 32.5 per fractional work
- Top-10% rate
- 43.1% record average 16.5%
- Open access
- 54% world 28%
Not ranked overall: Cvergenx (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Cvergenx (United States) publish most on?
By volume in 2022–2025: Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Esophageal Cancer Research and Treatment and Head and Neck Cancer Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Bladder and Urothelial Cancer Treatments Surgery 0 works
- 2 Urinary and Genital Oncology Studies Surgery 0 works
- 3 Esophageal Cancer Research and Treatment Surgery 0 works
- 4 Head and Neck Cancer Studies Otorhinolaryngology 0 works
- 5 Effects of Radiation Exposure Radiology, Nuclear Medicine and Imaging 0 works
- 6 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Cvergenx (United States)'s research output changed?
Other research institutions in Tampa
- University of South Florida
- Moffitt Cancer Center
- University of Tampa
- James A. Haley Veterans' Hospital
- Tampa General Hospital
- Atkins (United States)
- Children's Cancer Center
- AdventHealth Tampa
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.